PI3K/Akt/mTOR-IN-2 - 99%, high purity , CAS No.2757804-89-8

  • ≥99%
Item Number
P646779
Grouped product items
SKUSizeAvailabilityPrice Qty
P646779-5mg
5mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$95.90
P646779-10mg
10mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$165.90
P646779-25mg
25mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$345.90
P646779-50mg
50mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$550.90
P646779-100mg
100mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$950.90
View related series
Akt mTOR PI3K PI3K/Akt/mTOR

Basic Description

Specifications & Purity99%
Storage TempStore at -20°C
Shipped InIce chest + Ice pads
Product Description

PI3K/Akt/mTOR-IN-2 is a PI3K/AKT/mTOR pathway inhibitor. PI3K/Akt/mTOR-IN-2 possess anti-cancer effects and selectivity against MDA-MB-231 cells with IC 50 value of 2.29 μM. PI3K/Akt/mTOR-IN-2 can induce cancer cell cycle arrest and apoptosis

In Vitro

PI3K/Akt/mTOR-IN-2 (compound 23) (0.5 - 100 μM; 72 hours) exhibits effective anti-cancer activity with IC 50 s of 2.29 - 24.63 μM, of which, IC 50 in MDA-MB-231 is 2.29 μM. PI3K/Akt/mTOR-IN-2 (1 μM, 2 μM and 4 μM; 24 hours) induces growth inhibition of MDA-MB-231 cells by cell cycle arrest at G0/G1. PI3K/Akt/mTOR-IN-2 (1 μM, 2 μM and 4 μM; 24, 48 and 72 hours) induces apoptosis in MDA-MB-231 cells with both dose- and time-dependent manners. PI3K/Akt/mTOR-IN-2 (1 μM, 2 μM and 4 μM; 48 hours) increases the expression of Bax, and decreases the expression of Bcl-2 in MDA-MB-231 cells. PI3K/Akt/mTOR-IN-2 (1 μM, 2 μM and 4 μM; 24 hours) induces mitochondria-dependent apoptosis in MDA-MB-231 cells through disruption of MMP, accumulation of ROS, depletion of GSH and elevation of intracellular Ca 2+. MCE has not independently confirmed the accuracy of these methods. They are for reference only. Cell Proliferation Assay Cell Line: PC3, BGC-823, A549, MCF-7, MDA-MB-231 cells and MCF-10A cellsConcentration: 0.5 - 100 μM Incubation Time: 72 hours Result: Exhibited effective anti-cancer activity with IC 50 s of 2.29 - 24.63 μM, of which, IC 50 in MDA-MB-231 was 2.29 μM. Cell Cycle Analysis Cell Line: MDA-MB-231Concentration: 1 μM, 2 μM and 4 μM Incubation Time: 24 hours Result: Induced growth inhibition of MDA-MB-231 cells by cell cycle arrest at G0/G1. Apoptosis Analysis Cell Line: MDA-MB-231Concentration: 1 μM, 2 μM and 4 μM Incubation Time: 24, 48 and 72 hours Result: Induced apoptosis in MDA-MB-231 cells with both dose- and time-dependent manners. Western Blot Analysis Cell Line: MDA-MB-231Concentration: 1 μM, 2 μM and 4 μM Incubation Time: 48 hours Result: Increased the expression of Bax, and decreased the expression of Bcl-2

Form:Solid

IC50& Target:IC 50 : 2.29 μM (PI3K/AKT/mTOR) in MDA-MB-231

Names and Identifiers

Canonical SMILES FC1=CC(F)=CC(C2OCCC3=C2NC4=C3C=CC=C4)=C1
Molecular Weight 285.29

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

Chemical and Physical Properties

SolubilityDMSO : ≥ 100 mg/mL (350.52 mM)

Related Documents

Solution Calculators